Literature DB >> 7678336

Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.

E Fikrig1, R Berland, M Chen, S Williams, L H Sigal, R A Flavell.   

Abstract

Antibodies in sera of 7 patients with neurologic manifestations of Lyme borreliosis and a monoclonal antibody (mAb H9724) to the flagellin of Borrelia burgdorferi have been shown to bind neural tissue. To identify the antibody binding site common to the B. burgdorferi flagellin and the neural tissue, we made recombinant fusion proteins expressing epitopes of flagellin. Antibodies in patients' sera and mAb H9724 bound within an 18-amino acid epitope (residues 208-225) in the central region of flagellin, whereas two other mAbs bound to epitopes mapping elsewhere in the protein. Antibodies in patients sera and mAb H9724 also bound to a human neuroblastoma cell line. Absorption of patients sera with a peptide, EGVQQEGAQQPA, corresponding to amino acids 213-224 of flagellin, inhibited binding to the neuroblastoma cell line. The data suggest that the immune response to a specific B-cell epitope within flagellin, shared by a human neuroblastoma cell line, may be involved in the pathogenesis of neuroborreliosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678336      PMCID: PMC45624          DOI: 10.1073/pnas.90.1.183

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms.

Authors:  L H Sigal
Journal:  Semin Arthritis Rheum       Date:  1989-02       Impact factor: 5.532

2.  Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth.

Authors:  V Preac Mursic; B Wilske; G Schierz; H W Pfister; K Einhäupl
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

3.  Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.

Authors:  J E Sears; E Fikrig; T Y Nakagawa; K Deponte; N Marcantonio; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

4.  Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide.

Authors:  W C Van Voorhis; L Schlekewy; H L Trong
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product.

Authors:  G S Gassmann; E Jacobs; R Deutzmann; U B Göbel
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

6.  Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi.

Authors:  C Collins; G Peltz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Borrelia burgdorferi--specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis.

Authors:  R Martin; J Ortlauf; V Sticht-Groh; U Bogdahn; S F Goldmann; H G Mertens
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

8.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Antigen-specific proliferation of CSF lymphocytes in Lyme disease.

Authors:  A R Pachner; A C Steere; L H Sigal; C J Johnson
Journal:  Neurology       Date:  1985-11       Impact factor: 9.910

10.  Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens.

Authors:  L H Sigal; A H Tatum
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

View more
  8 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Analysis of the humoral response to the flagellin protein of Borrelia burgdorferi.

Authors:  T Schneider; R Lange; W Weigelt
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 3.  Lyme disease vaccine.

Authors:  G P Wormser
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 4.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

5.  Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

6.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

7.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.

Authors:  E Fikrig; H Tao; M Chen; S W Barthold; R A Flavell
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.